Results 231 to 240 of about 404,123 (293)

Therapeutic Effects of Single and Combined Anti-Disseminated Intravascular Coagulation (DIC) Drugs in a Rat Venom-Induced Consumption Coagulopathy (VICC) Model Using Yamakagashi (<i>Rhabdophis tigrinus</i>) Venom. [PDF]

Toxins (Basel)
Yamamoto A, Ito T, Hifumi T.
europepmc   +1 more source

Venom variation and the future of antivenom design: Integrating population venomics, evolutionary toxinology, and precision therapeutics. [PDF]

Toxicon X
Dingwoke EJ.
europepmc   +1 more source

Nicotinamide Ameliorates Deoxynivalenol-Induced Injury in Renal Cells via Inhibiting PARP1 Hyperactivation and Restoring NAD⁺ Homeostasis. [PDF]

Toxins (Basel)
Chen C, Qin Y, Luo Z, Mu P, Wen J, Deng Y.   +5 more
europepmc   +1 more source

Identification and Thermal Stability Modification of a Zearalenone Lactone Hydrolase ZHD30L. [PDF]

Toxins (Basel)
Liu X, Zhao F, Sahibzada KI, Zhang Y, Wei S, Tian P, Wang Y, Hu Y, Lv Y.   +8 more
europepmc   +1 more source

Sensing the spectrum: diverse stimuli for the NLRP3 inflammasome. [PDF]

Commun Biol
Xiao N, Lu Z, Chen J.
europepmc   +1 more source

Development of a Broad-Spectrum Antiserum against Cobra Venoms Using Recombinant Three-Finger Toxins

Toxins, 2021
[[abstract]]Three-finger toxins (3FTXs) are the most clinically relevant components in cobra (genus Naja) venoms. Administration of the antivenom is the recommended treatment for the snakebite envenomings, while the efficacy to cross-neutralize the ...
Wang-Chou Sung
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

RECOMBINANT TOXINS AS NOVEL THERAPEUTIC AGENTS

Annual Review of Biochemistry, 1992
PERSPECTIVE 331 PSE UDOMONAS EXOTOXIN 332 Structure and Function . . . . . . . . . . . _ .. ........ . _ . .. . . .... _ _ . . . . . .. . . _ . . . . . . . . . . . . . . . . . . . . . . . . . 332 PE40 .. . . .... ... . . . ....... . . ......... . .. 338 lmmunotoxins 338 Recombinant Toxins . . . . . . . . . . . . . . . . . . . . . . . . . . .
I, Pastan, V, Chaudhary, D J, FitzGerald
openaire   +3 more sources

Recombinant Toxins for Cancer Treatment

Science, 1991
Recombinant toxins target cell surface receptors and antigens on tumor cells. They kill by mechanisms different from conventional chemotherapy, so that cross resistance to conventional chemotherapeutic agents should not be a problem. Furthermore, they are not mutagens and should not induce secondary malignancies or accelerate progression of benign ...
I, Pastan, D, FitzGerald
openaire   +2 more sources

Evaluation of a recombinant tetanus toxin subunit vaccine

Toxicon, 2020
Tetanus is an acute, fatal disease caused by exotoxin produced by Clostridium tetani. The current vaccine against tetanus is based on inactivated tetanus toxin (TeNT). To develop a recombinant TeNT vaccine suitable for replacement of full-length tetanus toxoid (TT) vaccine for use in humans, a recombinant non-tagged isoform of the Hc domain of the ...
Fu-Jia, Liu, Dan-Yang, Shi, Zhi-Ying, Li, Jian-Sheng, Lu, Rong, Wang, Xiao-Bin, Pang, Zhi-Xin, Yang, Yun-Zhou, Yu   +7 more
openaire   +2 more sources

Recombinant fluorescent models for studying the diphtheria toxin

Russian Journal of Bioorganic Chemistry, 2014
Diphtheria toxin is the main pathogenicity factor of causative agent of diphtheria Corynebacterium diphtheriae. Due to the small molecule size, it is of considerable interestfor the development of synthetic protein molecules with transporting function, e.g. immunotoxins.
A Iu, Labyntsev, N V, Korotkevich, K Iu, Manoĭlov, A A, Kaberniuk, D V, Kolibo, S V, Komisarenko   +5 more
openaire   +2 more sources